Eisai
4523.T
#1780
Rank
โ‚ฌ8.68 B
Marketcap
30,79ย โ‚ฌ
Share price
0.57%
Change (1 day)
-37.89%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): 2,05ย โ‚ฌ

According to Eisai's latest financial reports the company's current EPS (TTM) is 2,02ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,48ย โ‚ฌ a decrease over its 2021 EPS that were of 6,59ย โ‚ฌ.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)2,05ย โ‚ฌ38.23%
20221,48ย โ‚ฌ-77.48%
20216,59ย โ‚ฌ-41.88%
202011,34ย โ‚ฌ-0.94%
201911,45ย โ‚ฌ52.59%
20187,50ย โ‚ฌ124.17%
20173,35ย โ‚ฌ-49.42%
20166,62ย โ‚ฌ37.08%
20154,83ย โ‚ฌ-11.75%
20145,47ย โ‚ฌ-3.23%
20135,65ย โ‚ฌ-18.56%
20126,94ย โ‚ฌ-15.51%
20118,22ย โ‚ฌ-3.75%
20108,54ย โ‚ฌ-1.36%
20098,65ย โ‚ฌ